Evidence map›Paper›PMID 23822755›Full record

ReviewExpert opinion on drug metabolism & toxicology2013

Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes.

Anusha Ande, Carole McArthur, Anil Kumar, Santosh Kumar

Open access · greenAbstract readReview
In one paragraph

Review in Expert opinion on drug metabolism & toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. HIV-HPV interactions via extracellular vesicles among tobacco smokers and nonsmokers.Experimental biology and medicine (Maywood, N.J.) · 2025
    Article
  4. Article
  5. PharmVar GeneFocus: CYP2A6.Clinical pharmacology and therapeutics · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  12. Independent and Combined Effects of Nicotine or Chronic Tobacco Smoking and HIV on the Brain: A Review of Preclinical and Clinical Studies.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anusha AndeUniversity of Missouri Kansas City, School of Pharmacy, Division of Pharmacology & Toxicology , Kansas City, MO 64108 , USA.
Carole McArthur
Anil Kumar
Santosh Kumar
University of Missouri–Kansas City · USWeatherford College · US

Funding

Tobacco/nicotine, cytochrome P450, and HIV-1R21DA031616 · NIDA · UNIVERSITY OF MISSOURI KANSAS CITY · PI KUMAR, SANTOSH · 2011 to 2012
$413k
NIDA NIH HHS DA031616-01NIDA NIH HHS R21 DA031616
6 · The paper itself

Abstract

introductionTobacco smoking is highly prevalent among the HIV-1-infected population. In addition to diminished immune response, smoking has been shown to increase HIV-1 replication and decrease response to antiretroviral therapy, perhaps through drug-drug interaction. However, the mechanism by which tobacco/nicotine increases HIV-1 replication and mediates drug-drug interaction is poorly understood. AREAS COVERED: In this review, the authors discuss the effects of smoking on HIV-1 pathogenesis. Since they propose a role for the cytochrome P450 (CYP) pathway in smoking-mediated HIV-1 pathogenesis, the authors briefly converse the role of CYP enzymes in tobacco-mediated oxidative stress and toxicity. Finally, the authors focus on the role of CYP enzymes, especially CYP2A6, in tobacco/nicotine metabolism and oxidative stress in HIV-1 model systems monocytes/macrophages, lymphocytes, astrocytes and neurons, which may be responsible for HIV-1 pathogenesis. EXPERT OPINION: Recent findings suggest that CYP-mediated oxidative stress is a novel pathway that may be involved in smoking-mediated HIV-1 pathogenesis, including HIV-1 replication and drug-drug interaction. Thus, CYP and CYP-associated oxidative stress pathways may be potential targets to develop novel pharmaceuticals for HIV-1-infected smokers. Since HIV-1/TB co-infections are common, future study involving interactions between antiretroviral and antituberculosis drugs that involve CYP pathways would also help treat HIV-1/TB co-infected smokers effectively.

Indexed as

Anti-Retroviral AgentsAstrocytesCytochrome P-450 Enzyme SystemDrug InteractionsHIV-1HIV InfectionsHumansLymphocytesMacrophagesMonocytesNeuronsNF-E2-Related Factor 2NicotianaNicotineOxidative StressProtein Kinase CAnti-Retroviral AgentsCytochrome P-450 Enzyme SystemNFE2L2 protein, humanNF-E2-Related Factor 2NicotineProtein Kinase C

Identifiers

PMID23822755
PMCPMC4007120
OpenAlexW1991137866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.